文献速递精神分裂症与精神病性障碍

首发精神病治疗反应的决定因素:18F-DOPA PET研究

Determinants of treatment response in first-episode psychosis: an 18F-DOPA PET study.
PubMed 文献 · Mol Psychiatry · 2018-04-20

该前瞻性队列嵌套病例对照研究对26例首发精神病患者和14名对照在抗精神病药治疗前进行18F-DOPA PET扫描测量纹状体多巴胺合成能力(DSC),并在基线及治疗至少4周后评估PANSS和GAF。结果显示应答者DSC显著高于非应答者和对照,且DSC与PANSS各项改善呈正相关,与GAF变化呈负相关。

要点

  • 首发精神病患者治疗前纹状体DSC可区分治疗应答者与非应答者。
  • DSC与PANSS阳性、阴性及总分改善正相关,与GAF变化负相关。
  • 应答者与非应答者的多巴胺功能差异在首发时即已存在。

核心结论

  • 临床治疗反应与基线纹状体多巴胺功能相关,应答者DSC显著高于非应答者和对照。

研究设计与样本

  • 前瞻性队列研究,嵌套病例对照比较,共40名志愿者(26例首发精神病患者和14名对照)在抗精神病药治疗前接受18F-DOPA PET扫描测量DSC(Kicer)。

主要发现

  • associative striatum的Kicer存在显著组效应(F(2, 37) = 7.9,p = 0.001)。
  • 应答者Kicer显著高于非应答者(Cohen's d = 1.55,p = 0.01)和对照(Cohen's d = 1.31,p = 0.02)。
  • Kicer与PANSS阳性改善(r = 0.64,p < 0.01)、PANSS阴性改善(rho = 0.51,p = 0.01)和PANSS总分改善(rho = 0.63,p < 0.01)呈显著正相关,与GAF变化呈负相关(r = -0.55,p < 0.01)。

关键数值与推荐

  • 应答定义为PANSS总分改善>50%。
  • 临床评估在基线及抗精神病药治疗至少4周后进行,患者随访至少6个月并应用缓解标准。

临床怎么用

  • 基线纹状体DSC可能有助于在首发精神病中区分治疗应答与非应答,为神经化学分层提供依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Psychotic illnesses show variable responses to treatment. Determining the neurobiology underlying this is important for precision medicine and the development of better treatments. It has been proposed that dopaminergic differences underlie variation in response, with striatal dopamine synthesis capacity (DSC) elevated in responders and unaltered in non-responders. We therefore aimed to test this in a prospective cohort, with a nested case-control comparison. 40 volunteers (26 patients with first-episode psychosis and 14 controls) received an 18F-DOPA Positron Emission Tomography scan to measure DSC (Kicer) prior to antipsychotic treatment. Clinical assessments (Positive and Negative Syndrome Scale, PANSS, and Global Assessment of Functioning, GAF) occurred at baseline and following antipsychotic treatment for a minimum of 4 weeks. Response was defined using improvement in PANSS Total score of >50%. Patients were followed up for at least 6 months, and remission criteria applied. There was a significant effect of group on Kicer in associative striatum (F(2, 37) = 7.9, p = 0.001). Kicer was significantly higher in responders compared with non-responders (Cohen's d = 1.55, p = 0.01) and controls (Cohen's d = 1.31, p = 0.02). Kicer showed significant positive correlations with improvements in PANSS-positive (r = 0.64, p < 0.01), PANSS negative (rho = 0.51, p = 0.01), and PANSS total (rho = 0.63, p < 0.01) ratings and a negative relationship with change in GAF (r = -0.55, p < 0.01). Clinical response is related to baseline striatal dopaminergic function. Differences in dopaminergic function between responders and non-responders are present at first episode of psychosis, consistent with dopaminergic and non-dopaminergic sub-types in psychosis, and potentially indicating a neurochemical basis to stratify psychosis.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Jauhar S, Veronese M, Nour MM, et al. Determinants of treatment response in first-episode psychosis: an 18F-DOPA PET study. Mol Psychiatry. 2018. PMID: 29679071. doi:10.1038/s41380-018-0042-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。